Gut barrier
You want it sealed and sound: an intact barrier underpins immunity, mood and digestion alike.
In depth
The intestinal barrier — the selective wall that admits nutrients, excludes toxins and anchors the gut–brain and immune dialogue.
What drives it
Parasite burden reduces it.
Three organisms, three unrelated groups, one endpoint — plus a human stool-leucocyte measurement. Verbatim: “intestinal barrier dysfunction upon G. duodenalis infection during which alterations of cellular ion transport were followed by breakdown of the tight junctional complex and loss of epithelial integrity.”. PMC5955458
Calms inflammation reduces it.
NF-κB/tight-junction study 2021, PLoS One — NF-κB activation induces myosin light-chain kinase (MLCK), increasing intestinal epithelial tight-junction permeability and disrupting the barrier. doi:10.1371/journal.pone.0249544. The mechanism is specific, not generic inflammation: barrier loss runs through NF-kappa-B p65 nuclear translocation driving myosin light chain kinase (MLCK) gene and protein expression, plus post-transcriptional modulation of occludin by microRNA. Loss-of-function is decisive here: knocking down NF-kappa-B p65 by siRNA prevented the MMP-9-induced IL-8 expression, prevented the MLCK protein increase, and prevented the rise in tight-junction permeability. A cell-type reversal worth knowing before any probiotic claim: Lactobacillus acidophilus prevented TNF-alpha-induced permeability by inhibiting NF-kappa-B p50/p65 and MLCK in intestinal cells (TLR-2-dependent, MyD88-INdependent) — while the same organism activated NF-kappa-B p50/p65 in immune cells (TLR-2- and MyD88-dependent). One probiotic, opposite effects on the same transcription factor, decided by cell type. 'Lowers NF-kappa-B' is not a coherent whole-body claim. Caco-2 monolayers in vitro plus animal models; the human cytokines shown to drive this route are IL-1-beta, TNF-alpha and IFN-gamma, in IBD (Crohn's, ulcerative colitis, necrotising enterocolitis, coeliac). doi 10.1371/journal.pone.0249544.
Calms histamine response reduces it.
Mast-cell tryptase cleaves protease-activated receptor 2 on the epithelium, redistributing the tight-junction proteins ZO-1 and occludin and pulling perijunctional F-actin into the cytosol — the junction physically opens (PMC10670774). In the human study, acute public speaking raised small-intestinal permeability (0.059 vs 0.030 control, p<0.01) with indomethacin as the positive comparator, and stabilizing mast cells abolished it (PMID 24153250). Acute stress decreases ZO-2 and occludin expression and opens the junction through an IFN-γ/MLCK route. PMID 24153250 · PMC10670774
Digestion increases it.
10.1038/s41467-017-00796-x — Digestive function and microbial ecology are mutually dependent. doi 10.1038/s41467-017-00796-x
Cell migration switch reduces it.
10.3389/fmed.2024.1368977 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). Verbatim: “In CD-associated intestinal fibrosis, epithelial-mesenchymal transition may serve as a source of new fibroblasts and consequently lead to overproduction of extracellular matrix”. doi 10.3389/fmed.2024.1368977
Fat burning increases it.
Verbatim: “One unifying theme is the induction of colonocyte hypoxia, driven by the aerobic oxidation of microbial-derived butyrate, as a critical factor promoting multiple cellular processes that support intestinal barrier function”. PMID 40405692
Immune support increases it.
10.3390/microorganisms7100440 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). Verbatim: “IgA mediates microbial homeostasis at the intestinal mucosa”. doi 10.3390/microorganisms7100440 · PMID 33568782
Inflammatory signaling increases it.
10.3389/fmed.2024.1368977 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). doi 10.3389/fmed.2024.1368977
Allergic signaling reduces it.
10.3389/fphar.2023.1301800 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). Verbatim: “IL-13 causes increased permeability and delayed repair of model colon epithelial cell monolayers by stimulating apoptosis and increasing expression of the pore-forming tight junction protein claudin-2”. doi 10.3389/fphar.2023.1301800 · PMC3120916
Innate immune sensor reduces it.
10.3390/microorganisms8121882 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). Verbatim: “Regarding mechanism, LPS modulated gut barrier dysfunction by the TLR4/NF-κB inflammatory signaling pathway, during which the LPS-activated TRL4 played an integral part in the phosphorylation of IκBa and p65 in the cytoplasm”. doi 10.3390/microorganisms8121882 · PMID 36973501 · PMC10366024
Calms body-wide inflammation reduces it.
10.1371/journal.pone.0152914 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). doi 10.1371/journal.pone.0152914
Inflammation signal (TNF-α) reduces it.
10.3389/fimmu.2024.1348010 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). doi 10.3389/fimmu.2024.1348010
H. pylori reduces it.
10.1016/j.nbd.2024.106458 — https://www.merckmanuals.com/professional/gastrointestinal-disorders/gastritis-and-peptic-ulcer-disease/helicobacter-pylori-infection — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). doi 10.1016/j.nbd.2024.106458
Oxidative stress reduces it.
10.3390/antiox15050533 — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). doi 10.3390/antiox15050533
What it drives
It increases Fullness hormone (CCK).
10.14814/phy2.70373 — exposure of cultured enteroendocrine cells to promiscuous bitter tastants (e.g. quinine) is known to increase intracellular calcium signaling and stimulate release of hormones, including cholecystokinin (CCK). 10.1093/ajcn/nqab418. doi 10.14814/phy2.70373
It reduces Lowers cortisol.
The microbiota-gut-brain axis regulates HPA activity in humans: in a randomized placebo-controlled trial, Bifidobacterium breve CCFM1025 significantly lowered PSQI scores in stress-induced insomnia and produced a more pronounced reduction in stress-marker concentrations (PMC10648101); a second RCT targeted the same melatonin/HPA route (PMC12787598). Convergent, and the founding evidence is a loss-of-function model: germ-free mice show exaggerated stress responses (Sudo 2004) — absence of microbiota alters HPA reactivity. Mechanistically, gut dysbiosis produces pro-inflammatory cytokines and microbial antigens that activate the HPA axis across the blood-brain barrier, and microbiota-host interaction releases cytokines that disrupt the BBB itself. The reviews note HPA overactivation is one cause of depression — one among several, not the account. Shared caveats on this whole row: (1) the route to the brain is not free — gut-derived neurotransmitters reach targets via the bloodstream and must cross the blood-brain barrier; elevated plasma 5-HT can itself raise BBB permeability, temporarily letting plasma 5-HT enter the CNS, so the barrier is a variable not a constant. (2) much of this literature is association — the reviews state plainly that the association studies linking microbiota to depression did not provide evidence on aetiology. (3) The enteric nervous system hosts more than 30 neurotransmitters; any single arrow is one strand of a dense web. PMC10648101
It increases Motivation.
The gut microbiome supplies and shapes dopamine: microbial decarboxylases (TDC/AADC) convert tyrosine and L-DOPA into dopamine in the intestinal lumen (PMC12837447), and a microbiome-dependent gut→brain circuit elevates striatal dopamine (PMC10264927). The limit: gut-made dopamine does not cross the blood-brain barrier — the central effect runs through neural/metabolite signaling, not direct transport. Convergent: dopamine is among the neuroactive molecules generated by both eukaryotes and prokaryotes, described as an interkingdom communication system; gut microbiota both produce and consume dopamine, norepinephrine, serotonin, GABA and glutamate, which reach cellular targets through the bloodstream. Produce and consume — the microbiota is a sink as well as a source, so the net direction is not guaranteed. Shared caveats on this whole row: (1) the route to the brain is not free — gut-derived neurotransmitters reach targets via the bloodstream and must cross the blood-brain barrier; elevated plasma 5-HT can itself raise BBB permeability, temporarily letting plasma 5-HT enter the CNS, so the barrier is a variable not a constant. (2) much of this literature is association — the reviews state plainly that the association studies linking microbiota to depression did not provide evidence on aetiology. (3) The enteric nervous system hosts more than 30 neurotransmitters; any single arrow is one strand of a dense web. PMC12837447
It increases Bile acid hormone.
Bile-acid/FXR–FGF19 review (PMC4465534) — bile acids activate FXR in ileal enterocytes to induce the enterohepatic hormone FGF15/19. PMC4465534. Mechanism: gut bacteria convert primary bile acids into secondary bile acids, which activate intestinal FXR; FXR then induces FGF19 in humans (FGF15 in mice) and SHP, and together these suppress CYP7A1, the rate-limiting enzyme of de novo bile-acid synthesis — a feedback signal from gut to liver. Loss-of-function is decisive and it is the microbiota that matters: in germ-free or antibiotic-treated mice, taurine-conjugated beta-muricholic acid accumulates; TbetaMCA is an FXR antagonist, and its accumulation reduced Fgf15 expression and raised Cyp7a1. Reduced bile-salt hydrolase activity likewise diminished secondary bile acids and inhibited FXR signaling. FGF19 in humans, FGF15 in mice — they are orthologues, not the same molecule. And inhibiting intestinal FXR altered bile-acid composition and decreased obesity incidence in mice, so more FXR signaling is not straightforwardly better. PMC4465534
It increases Memory chemical.
Gut-ACh finding 1977, Appl Environ Microbiol 34:237 — gut bacteria such as Lactobacillus plantarum synthesize acetylcholine, contributing to the host cholinergic pool. doi:10.1128/aem.34.2.237-239.1977. Convergent: acetylcholine is the most common cholinergic neurotransmitter in the intestinal tract, synthesized from choline and acetyl-CoA by choline acetyltransferases and released by sympathetic preganglionic and parasympathetic pre- and postganglionic fibers. Microbial ACh production was first identified in L. plantarum. much of the intestinal ACh is host-derived from enteric neurons; the microbial contribution is a component, not the source. Shared caveats on this whole row: (1) the route to the brain is not free — gut-derived neurotransmitters reach targets via the bloodstream and must cross the blood-brain barrier; elevated plasma 5-HT can itself raise BBB permeability, temporarily letting plasma 5-HT enter the CNS, so the barrier is a variable not a constant. (2) much of this literature is association — the reviews state plainly that the association studies linking microbiota to depression did not provide evidence on aetiology. (3) The enteric nervous system hosts more than 30 neurotransmitters; any single arrow is one strand of a dense web. doi 10.1128/aem.34.2.237-239.1977.
It increases Calm.
Strandwitz 2019, Nat Microbiol — human gut bacteria (e.g. Bacteroides) produce the inhibitory neurotransmitter GABA; germ-free animals show reduced luminal/serum GABA. PMID 30531975. Convergent and mechanistic: gut bacteria carry gad genes encoding glutamate decarboxylase and produce GABA from dietary glutamate. Bifidobacterium adolescentis is identified as a model human-gut GABA producer, with two high-producing strains found by in vitro screening of 82 strains, and Bacteroides GABA pathways confirmed by transcriptome analysis. Specific the B. adolescentis / mental-health link comes from in silico metagenomic correlation, described by the authors as an association — not an intervention. Shared caveats on this whole row: (1) the route to the brain is not free — gut-derived neurotransmitters reach targets via the bloodstream and must cross the blood-brain barrier; elevated plasma 5-HT can itself raise BBB permeability, temporarily letting plasma 5-HT enter the CNS, so the barrier is a variable not a constant. (2) much of this literature is association — the reviews state plainly that the association studies linking microbiota to depression did not provide evidence on aetiology. (3) The enteric nervous system hosts more than 30 neurotransmitters; any single arrow is one strand of a dense web. PMID 30531975
It increases Appetite & sugar hormone.
SCFA/GLP-1 study 2015, Int J Obes — gut microbiota-derived short-chain fatty acids (e.g. propionate) stimulate GLP-1 (incretin) secretion from enteroendocrine L-cells via FFAR2/GPR43. PMC4356745. Mechanism: gut bacteria ferment non-digestible fiber in the colon into short-chain fatty acids, which act as signaling molecules binding FFAR2 (GPR43) and FFAR3 (GPR41) on enteroendocrine L-cells to trigger GLP-1 release. Separately, bacteria convert primary to secondary bile acids, which activate GPBAR1 and also release GLP-1. But the same bile acids apply a brake through a second receptor, and the knockout proves it: activation of intestinal FXR is inhibitory to GLP-1 release, reducing FFAR2 expression. SCFA-induced GLP-1 was blunted in colonic biopsies from FXR-agonist-treated mice and enhanced in FXR-knockout colonoids; FXR-KO mice showed elevated colonic FFAR2 mRNA and increased plasma GLP-1 on prebiotic supplementation. Two bile-acid receptors, opposite directions. A further paradox the authors name: propionate activates FFAR3, which couples to Gi/o and lowers cAMP — yet still enhances GLP-1, because it simultaneously engages intestinal gluconeogenesis and vagal afferent signaling. colonic L-cells; much of the causal work is mouse colonoids and knockouts, with human NCI-H716 L-cells in vitro. PMC4356745
It increases Mood (serotonin).
Yano 2015, Cell 161:264 — indigenous gut microbiota promote serotonin (5-HT) biosynthesis from colonic enterochromaffin cells, supplying 5-HT to mucosa and circulation. PMID 25860609. Convergent, and the mechanism is dual: specific probiotic species facilitate the metabolic conversion of tryptophan to serotonin, and separately suppress MAO-A activity via short-chain fatty acids — raising serotonin bioavailability by both synthesis and reduced degradation. The reviewers frame this as bidirectional regulation of synthetic and degrading enzymes. Shared caveats on this whole row: (1) the route to the brain is not free — gut-derived neurotransmitters reach targets via the bloodstream and must cross the blood-brain barrier; elevated plasma 5-HT can itself raise BBB permeability, temporarily letting plasma 5-HT enter the CNS, so the barrier is a variable not a constant. (2) much of this literature is association — the reviews state plainly that the association studies linking microbiota to depression did not provide evidence on aetiology. (3) The enteric nervous system hosts more than 30 neurotransmitters; any single arrow is one strand of a dense web. PMID 25860609
It increases Gut-brain signal.
Bonaz 2018, Front Neurosci 12:49 — vagal afferents sense gut luminal and microbial signals (via EEC-released 5-HT/CCK/GLP-1), relaying gut state to the brain. PMC5808284
It increases Digestion.
Intestinal-barrier review 2020 — a functional intestinal barrier enables nutrient and fluid absorption while excluding pathogens; gut microbiota sustains barrier integrity and aids digestion. PMC7463717
It reduces Calm under stress.
Two-sample bidirectional Mendelian randomization over 119 bacterial genera found specific gut genera causally related to anxiety disorders, with multivariable analysis pointing to a metabolite-dependent mechanism driven partly by cortisol (PMC11035889). Note: Mendelian randomization is causal inference from genetic instruments, not a randomized trial. PMC11035889
It reduces Brain inflammation.
10.1038/nn.4030 — ,germ-free mice display global defects in microglia and show immature microglia with reduced pro-inflammatory cytokine production. The requirement is continuous, not developmental: even during adulthood, continuous input from complex microbiota is necessary for maintenance of normal microglia — and if the input is lost, for example after antibiotics, microglia return to an immature status. A course of antibiotics de-matures the brain's immune cells. So the arrow is not read as gut causes brain inflammation. It is: the gut keeps microglia mature and responsive. Absence gives immature, hypo-responsive cells — which is why germ-free animals show reduced amyloid pathology, a benefit, in the same literature. doi 10.1038/nn.4030
It reduces Quiets overexcitation.
NMR of germ-free versus specific-pathogen-free mouse brain found brain acetate significantly reduced in germ-free animals (p=0.012) while glutamate (p=0.0013), glutamine (p=0.0006) and N-acetyl aspartate (p=0.0046) were increased — so the presence of a microbiome lowers brain glutamate, which is why this edge is drawn inhibitory. And it tracks a functional readout: cFOS mRNA was significantly decreased in the prefrontal cortex of germ-free mice (p=0.044) and correlated with the abundance of the altered metabolites including glutamate and glutamine. germ-free animals are a causal tool but an extreme one — no human has this phenotype. The finding establishes that the microbiome sets brain glutamate tone, not the size of that effect in a colonized human. doi 10.3389/fnmol.2023.1155620
It increases Mood.
Transmitter supply: gut microbiota influence 5-HT, dopamine, norepinephrine, glutamate and GABA and modulate tryptophan metabolism — roughly 90 percent of serotonin is made peripherally by enterochromaffin cells. Barrier and immune: changes in gut microbiota can damage the gut barrier and increase peripheral inflammatory cytokines. Neurotrophin: short-chain fatty acids such as butyrate increase BDNF, whereas dysbiosis decreases it. Germ-free animals show altered brain structure, behavior and emotional regulation. The reviewers state the limit plainly: more clinical trials ARE required to determine whether probiotics ARE effective in treating depression, and the underlying mechanisms need to be elucidated. A rich mechanism with an unproven intervention. doi 10.1002/mco2.156
Blends that modulate it
Each blend page names this pathway and carries the study behind its claim.
See it on the map
Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.